ITI Life Sciences Appoints Dr Ford Kennedy as Director of Commercialisation
ITI Life Sciences announced the appointment of Dr Ford Kennedy as its new Director of Commercialisation. Dr Kennedy has extensive commercial experience in the bioscience industry from a career in business development, sales and marketing and technology commercialisation spanning 22 years. Most recently he was Director, Scientific Sourcing and New Technologies at Millipore Corporation.
Dr Kennedy's role at ITI Life Sciences is to identify commercial opportunities and secure licences for its portfolio of new technologies and intellectual property resulting from the ITI research programmes that are approaching completion in 2008 and beyond.
These first programmes were established in 2005, with funding from ITI Life Sciences, to develop new technologies in commercially attractive areas, such as diagnostics and drug discovery and development, and which are predicted to become increasingly important to the life sciences sector. By creating successful research programmes that capitalise on the scientific excellence in Scotland combined with that of international commercial partners, ITI Life Sciences aims to position Scotland as a world-class location for life sciences R&D and to promote growth of the Scottish life sciences sector.
Other news from the department price development
